New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

IHIvsFTXHETF Comparison

ETF 1
IHI

iShares U.S. Medical Devices ETF

This fund is part of
US Health Care
+0.69%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+0.69%

iShares U.S. Medical Devices ETF (IHI) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. IHI's top 3 sector exposures are Healthcare, Non-Corporate and Finance. In contrast, FTXH's top sector exposures are Healthcare. IHI is less expensive with a Total Expense Ratio (TER) of 0.37%, versus 0.6% for FTXH. IHI is down -11.74% year-to-date (YTD) with +$80M in YTD flows. FTXH performs better with 31.84% YTD performance, and +$1.02B in YTD flows. Run a side-by-side ETF comparison of IHI and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHI vs FTXH performance and flow charts

Performance

-4.0-2.00.02.04.06.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

-300 M-200 M-100 M0 M100 MSep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/28/2026
1M3MYTD1Y3Y5Y
Perf.
IHI
FTXH
+5.14%+3.28%
+3.88%+9.09%
-11.74%+31.84%
-11.24%+47.80%
+24.60%+87.39%
-13.56%+77.36%
Flows
IHI
FTXH
-$66M+$41M
+$375M+$176M
+$80M+$1.02B
-$127M+$1.02B
-$2.07B+$1.02B
-$3.75B+$1.02B
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHI
FTXH
+19.31%+18.78%
+20.65%+17.62%
+18.24%+17.11%
+19.85%+16.43%
Max drawdown
IHI
FTXH
-10.77%-5.45%
-26.18%-7.50%
-26.72%-19.32%
-32.36%-19.32%
Max drawdown duration
IHI
FTXH
70d57d
337d99d
630d393d
1766d393d
Trading data

Create an account to view trading data

Join for free
IHI
FTXH
Last sale
10/29/2026 at 1:30 PM
$55.69
$43.77
Previous close
10/28/2026
$54.64
$43.25
Consolidated volume
10/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHI
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
IHI
FTXH
Last price
$55.69
$43.77
1D performance
+1.92%
+1.22%
AuM$3.67 B$1.16 B
E/R0.37%0.6%
Characteristics
IHI
FTXH
Management strategyPassivePassive
ProvideriSharesFirst Trust
BenchmarkDow Jones U.S. Select Medical Equipment IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings4749
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

IHI
USA
91.36%
Ireland
7.77%
Other
0.87%
FTXH
USA
95.82%
Other
4.18%

Sectors

IHI
Healthcare
99.87%
Other
0.13%
FTXH
Healthcare
99.79%
Other
0.21%
Advertisement

Diversification

IHI

Total weight of top 15 holdings out of 15

88.16%
FTXH

Total weight of top 15 holdings out of 15

67.15%

Top 15 holdings

Data as of August 31, 2026
IHI
Abbott Laboratories
18.54%
Intuitive Surgical, Inc.
12.87%
Stryker Corp.
10.77%
Becton, Dickinson & Co.
5.18%
DexCom, Inc.
4.90%
ResMed, Inc.
4.85%
Medtronic Plc
4.59%
GE Healthcare Technologies, Inc.
4.52%
Edwards Lifesciences Corp.
4.29%
IDEXX Laboratories, Inc.
4.07%
Boston Scientific Corp.
4.06%
STERIS Plc (Ireland)
3.18%
Zimmer Biomet Holdings, Inc.
2.70%
Baxter International, Inc.
1.87%
Penumbra, Inc.
1.77%
FTXH
Merck & Co., Inc.
7.62%
AbbVie, Inc.
7.05%
Eli Lilly & Co.
6.92%
Johnson & Johnson
6.87%
Bristol Myers Squibb Co.
6.75%
Amgen, Inc.
3.56%
Biogen, Inc.
3.54%
Viatris, Inc.
3.51%
Vertex Pharmaceuticals, Inc.
3.48%
Regeneron Pharmaceuticals, Inc.
3.33%
Cardinal Health, Inc.
3.29%
Pfizer Inc.
3.25%
Gilead Sciences, Inc.
3.16%
Incyte Corp.
2.43%
United Therapeutics Corp.
2.39%
Frequently asked questions about IHI and FTXH

How have the IHI and FTXH ETFs performed in 2026?

As of October 28, 2026, IHI is down -11.74% year-to-date (YTD), while FTXH has returned 31.84%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: IHI or FTXH?

Year-to-date, the IHI ETF saw +$80M in flows, compared to +$1.02B for FTXH.

Which ETF is more volatile: IHI or FTXH?

Over the past year, IHI had a volatility of 20.65%, while FTXH experienced 17.62%.

Which ETF is bigger: IHI or FTXH?

As of October 28, 2026, IHI holds $3.67 B in assets under management (AUM), while FTXH manages $1.16 B.

What sectors do the IHI and FTXH ETFs invest in?

IHI leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the IHI ETF and FTXH ETF?

IHI top holdings include Abbott Laboratories, Intuitive Surgical, Inc. and Stryker Corp.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

Which ETF is more diversified: IHI or FTXH?

IHI holds 47 securities with 88.16% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 67.15%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026